anurajms/meta_analysis huggingface dataset:
Provide patient population that should be included in the study
Vitamin A supplementation during pregnancy for maternal and newborn outcomes
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Yoga versus standard care for schizophrenia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Schizophrenic Related Disorders 6. Schizophrenia 7. Aged 65-79 years
Provide patient population that should be included in the study
Cordyceps sinensis (a traditional Chinese medicine) for kidney transplant recipients
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. End Stage Kidney Disease 6. Middle Aged 45-64 years 7. Infant 1 to 23 mo 8. Kidney transplant 9. Young Adult 19-24 years 10. Birth to 1 mo 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for preventing and treating low‐back and pelvic pain during pregnancy
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Low back pain 4. Young Adult 19-24 years 5. Pregnancy 6. Pelvic Pain 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Vitamin C supplementation in pregnancy
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Nut consumption for the primary prevention of cardiovascular disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Vitamin K for the primary prevention of cardiovascular disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. General Health Good 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for nausea and vomiting in early pregnancy
1. Adult 19-44 years 2. First Trimester Pregnancy 3. Middle Aged 45-64 years 4. Second Trimester Pregnancy 5. Vomiting 6. Young Adult 19-24 years 7. Retching 8. Nausea 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Vitamin E supplementation in pregnancy
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Electromagnetic therapy for treating pressure ulcers
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Pressure ulcer 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Massage for low‐back pain
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Low back pain 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Transcranial magnetic stimulation (TMS) for schizophrenia
1. Schizophrenia
Provide patient population that should be included in the study
Alginate dressings for venous leg ulcers
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Venous leg ulcer 6. Aged 65-79 years
Provide patient population that should be included in the study
Transcutaneous electrical nerve stimulation (TENS) for phantom pain and stump pain following amputation in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Phantom Pain 5. Young Adult 19-24 years 6. Limb Stump Pain 7. Aged 65-79 years 8. Adolescent 13-18 years 9. Limb amputation
Provide patient population that should be included in the study
Effects of total fat intake on body weight
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Cardiovascular disease 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Selenium supplementation for critically ill adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Surgery 5. Young Adult 19-24 years 6. Critical Illness 7. Aged 65-79 years
Provide patient population that should be included in the study
Hyperbaric oxygen therapy for acute coronary syndrome
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Acute Coronary Syndrome
Provide patient population that should be included in the study
Oral zinc for the prevention of hyperbilirubinaemia in neonates
1. Term infant (37-41 weeks) 2. Birth to 1 mo 3. Preterm Infant
Provide patient population that should be included in the study
Supplementation with long chain polyunsaturated fatty acids (LCPUFA) to breastfeeding mothers for improving child growth and development
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Breast Fed 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Capsaicin for non‐allergic rhinitis
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Adolescent 13-18 years 7. Non-allergic Rhinitis
Provide patient population that should be included in the study
Pilates for low back pain
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Low back pain 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Electromagnetic therapy for treating venous leg ulcers
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Venous leg ulcer 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Massage therapy for preventing pressure ulcers
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years
Provide patient population that should be included in the study
Transcutaneous electrical nerve stimulation for acute pain
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Acute Pain 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Qigong for the primary prevention of cardiovascular disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. At Risk Of Disease 6. Aged 65-79 years 7. Healthy 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Vitamin K for upper gastrointestinal bleeding in people with acute or chronic liver diseases
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Disease Of Liver 10. Aged 65-79 years 11. Gastrointestinal Bleeding 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Chinese herbal medicine for treating recurrent urinary tract infections in women
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Urinary Tract Infection 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Insulin Resistance 6. Aged 65-79 years
Provide patient population that should be included in the study
Oral protein calorie supplementation for children with chronic disease
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Birth to 1 mo 5. Chronic Disease 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Alginate dressings for treating pressure ulcers
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Pressure ulcer 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Tong‐xin‐luo capsule for patients with coronary heart disease after percutaneous coronary intervention
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Coronary Heart Disease 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Percutaneous Coronary Intervention 12. Adolescent 13-18 years
Provide patient population that should be included in the study
L‐acetylcarnitine for treating fragile X syndrome
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Fragile X Syndrome 7. Young Adult 19-24 years 8. Aged 65-79 years 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Chelation for autism spectrum disorder (ASD)
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Autism Spectrum Disorder 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Vitamin D for the treatment of chronic painful conditions in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Chronic Disease 6. Aged 65-79 years 7. Chronic Pain
Provide patient population that should be included in the study
Saline nasal irrigation for acute upper respiratory tract infections
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Acute Upper Respiratory Infection 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Feverfew for preventing migraine
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Migraine 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Chinese medicinal herbs for mumps
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Mumps 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Exercise programs for people with dementia
1. Aged 80 and over 80+ years 2. Aged 65-79 years 3. Dementia
Provide patient population that should be included in the study
Omega 3 fatty acids for preventing or slowing the progression of age‐related macular degeneration
1. Aged 80 and over 80+ years 2. Middle Aged 45-64 years 3. Age-related Macular Degeneration 4. Aged 65-79 years 5. Healthy
Provide patient population that should be included in the study
Quinine for muscle cramps
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Muscle Cramp 9. Nocturnal Muscle Spasm 10. Birth to 1 mo 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Reiki for depression and anxiety
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Anxiety Disorder 5. Depression 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Xylitol‐containing products for preventing dental caries in children and adults
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Honey as a topical treatment for wounds
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Child 6-12 years 4. Laceration 5. Infant 1 to 23 mo 6. Skin injury 7. Pressure ulcer 8. Wound 9. Aged 65-79 years 10. Adolescent 13-18 years 11. Burn 12. Adult 19-44 years 13. Middle Aged 45-64 years 14. Wound Infected 15. Young Adult 19-24 years 16. Skin Ulcer 17. Birth to 1 mo
Provide patient population that should be included in the study
Muscle energy technique for non‐specific low‐back pain
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Low back pain 4. Young Adult 19-24 years
Provide patient population that should be included in the study
Morita therapy for anxiety disorders in adults
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Anxiety Disorder 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Dance movement therapy for depression
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Depression 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Cardiovascular Event Risk 6. Aged 65-79 years
Provide patient population that should be included in the study
Chinese herbal medicines for hypothyroidism
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Hypothyroidism 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Acupuncture for mumps in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Mumps 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Homeopathic Oscillococcinum® for preventing and treating influenza and influenza‐like illness
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Influenza-like illness 8. Influenza 9. Young Adult 19-24 years 10. Birth to 1 mo 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Complementary therapies for acne vulgaris
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Child 6-12 years 4. Infant 1 to 23 mo 5. Acne 6. Aged 65-79 years 7. Adolescent 13-18 years 8. Adult 19-44 years 9. Middle Aged 45-64 years 10. Inflammatory Acne 11. Young Adult 19-24 years 12. Birth to 1 mo 13. Juvenile Acne
Provide patient population that should be included in the study
Vitamin B and its derivatives for diabetic kidney disease
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Chronic Kidney Disease Due To Type I Diabetes Mellitus 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Mailuoning for acute ischaemic stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Ischemic Stroke 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Immunonutrition as an adjuvant therapy for burns
1. Aged 80 and over 80+ years 2. Burn 3. Adult 19-44 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Creatine for women in pregnancy for neuroprotection of the fetus
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Reduced dietary salt for the prevention of cardiovascular disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Cordyceps sinensis (a traditional Chinese medicine) for treating chronic kidney disease
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Chronic Kidney Disease 8. Aged 65-79 years 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromes
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Congenital Myasthenia 8. Neonatal Myasthenia Gravis 9. Aged 65-79 years 10. Myasthenia Gravis 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Glutamine supplementation for young infants with severe gastrointestinal disease
1. Gastrointestinal Surgery 2. Necrotizing Enterocolitis 3. Birth to 1 mo 4. Neonatal Gastrointestinal Disorder
Provide patient population that should be included in the study
NA
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Acute Pain 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Music interventions for mechanically ventilated patients
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Child 6-12 years 4. Infant 1 to 23 mo 5. Critical Illness 6. Aged 65-79 years 7. Adolescent 13-18 years 8. Adult 19-44 years 9. Middle Aged 45-64 years 10. Young Adult 19-24 years 11. Birth to 1 mo 12. Intensive Care 13. Mechanical ventilation
Provide patient population that should be included in the study
Co‐enzyme Q10 supplementation for the primary prevention of cardiovascular disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years
Provide patient population that should be included in the study
Garlic for the common cold
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Common Cold 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Decongestants, antihistamines and nasal irrigation for acute sinusitis in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Acute Sinusitis 5. Birth to 1 mo 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Probiotics for preventing ventilator‐associated pneumonia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Ventilator Associated Pneumonia 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Intensive Care 7. Mechanical ventilation 8. Aged 65-79 years
Provide patient population that should be included in the study
Astragalus (a traditional Chinese medicine) for treating chronic kidney disease
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Chronic Kidney Disease 8. Aged 65-79 years 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Acupuncture for schizophrenia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Schizophrenic Related Disorders 6. Schizophrenia 7. Schizophreniform Psychosis, Depressive Type 8. Aged 65-79 years
Provide patient population that should be included in the study
Cannabis and schizophrenia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Schizophrenia 6. Aged 65-79 years
Provide patient population that should be included in the study
Acupuncture for functional dyspepsia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Indigestion 6. Aged 65-79 years
Provide patient population that should be included in the study
Repetitive transcranial magnetic stimulation (rTMS) for panic disorder in adults
1. Adult 19-44 years 2. Panic Disorder 3. Middle Aged 45-64 years 4. Young Adult 19-24 years
Provide patient population that should be included in the study
Glutamine supplementation for critically ill adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Elective Surgery 4. Middle Aged 45-64 years 5. Surgery 6. Young Adult 19-24 years 7. Critical Illness 8. Aged 65-79 years
Provide patient population that should be included in the study
Oral zinc for arterial and venous leg ulcers
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Arteritic Leg Ulcer 9. Birth to 1 mo 10. Venous leg ulcer 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Antioxidants for pain in chronic pancreatitis
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Pain 5. Chronic Pancreatitis 6. Young Adult 19-24 years 7. Aged 65-79 years
Provide patient population that should be included in the study
Chinese herbal medicines for treating skin and soft‐tissue infections
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Ski infection 5. Young Adult 19-24 years 6. Soft Tissue Infection 7. Aged 65-79 years
Provide patient population that should be included in the study
Phototherapy for treating pressure ulcers
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Pressure ulcer 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Zinc supplements for preventing otitis media
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Aged 65-79 years 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Acupuncture for treating acute ankle sprains in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Sprain Of Ankle 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Creatine for Parkinson's disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Parkinson's Disease 6. Aged 65-79 years
Provide patient population that should be included in the study
Vitamins C and E for asthma and exercise‐induced bronchoconstriction
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Exercise-induced Asthma 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years 12. Asthma
Provide patient population that should be included in the study
Oral herbal therapies for treating osteoarthritis
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Osteoarthritis 6. Aged 65-79 years
Provide patient population that should be included in the study
Horticultural therapy for schizophrenia
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Adolescent 13-18 years
Provide patient population that should be included in the study
Vitamin D supplementation for cystic fibrosis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Cystic Fibrosis 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Acupuncture for epilepsy
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Epilepsy 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Vitamin D and vitamin D analogues for preventing fractures in post‐menopausal women and older men
1. Aged 80 and over 80+ years 2. Middle Aged 45-64 years 3. Postmenopausal 4. Aged 65-79 years
Provide patient population that should be included in the study
Cannabinoids for epilepsy
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Epilepsy 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Chinese herbal medicines for benign thyroid nodules in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Thyroid Nodule 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementia
1. Dementia
Provide patient population that should be included in the study
Echinacea for preventing and treating the common cold
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Common Cold 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Psychological and educational interventions for atopic eczema in children
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Child 6-12 years 4. Adult 19-44 years 5. Middle Aged 45-64 years 6. Atopic Dermatitis 7. Infant 1 to 23 mo 8. Parent 9. Young Adult 19-24 years 10. Birth to 1 mo 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Music for stress and anxiety reduction in coronary heart disease patients
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Coronary Heart Disease 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Electromagnetic fields for treating osteoarthritis
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Osteoarthritis 6. Aged 65-79 years
Provide patient population that should be included in the study
Phytoestrogens for menopausal vasomotor symptoms
1. Perimenopausal 2. Middle Aged 45-64 years 3. Postmenopausal
Provide patient population that should be included in the study
Dietary advice for reducing cardiovascular risk
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Cardiovascular disease 6. Aged 65-79 years
Provide patient population that should be included in the study
Chromium picolinate supplementation for overweight or obese adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Obesity 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Overweight
Provide patient population that should be included in the study
Vitamin C for asthma and exercise‐induced bronchoconstriction
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Aged 65-79 years 8. Adolescent 13-18 years 9. Asthma
Provide patient population that should be included in the study
Pelargonium sidoides extract for treating acute respiratory tract infections
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Acute Respiratory Tract Infection 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
'Third wave' cognitive and behavioural therapies versus treatment as usual for depression
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Depression 6. Aged 65-79 years
Provide patient population that should be included in the study
Chinese herbal medicine for diabetic peripheral neuropathy
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Diabetic Peripheral Neuropathy 6. Aged 65-79 years
Provide patient population that should be included in the study
Dance therapy for schizophrenia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Schizophrenia 6. Aged 65-79 years
Provide patient population that should be included in the study
Interventions for replacing missing teeth: hyperbaric oxygen therapy for irradiated patients who require dental implants
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Teeth missing 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Radiotherapy 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Chinese herbal medicine for atopic eczema
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Atopic Dermatitis 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Aged 65-79 years 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Acupuncture and assisted reproductive technology
1. Adult 19-44 years 2. Subfertility 3. In Vitro Fertilization 4. Young Adult 19-24 years
Provide patient population that should be included in the study
Respiratory muscle training for cervical spinal cord injury
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Cervical Spinal Cord Injury 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Homocysteine lowering interventions for peripheral arterial disease and bypass grafts
1. Adult 19-44 years 2. Hyperhomocysteinaemia 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Peripheral Arterial Disease 6. Bypass Graft 7. Aged 65-79 years
Provide patient population that should be included in the study
Thiamine for prevention and treatment of Wernicke‐Korsakoff Syndrome in people who abuse alcohol
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Alcoholism 5. Young Adult 19-24 years 6. Korsakoff's Psychosis 7. Aged 65-79 years
Provide patient population that should be included in the study
Uterine massage for preventing postpartum haemorrhage
1. Adult 19-44 years 2. Cesarean Section 3. Middle Aged 45-64 years 4. Postpartum 5. Young Adult 19-24 years 6. Vaginal Delivery 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Alginate dressings for healing diabetic foot ulcers
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Child 6-12 years 4. Infant 1 to 23 mo 5. Diabetic Foot Ulcer 6. Aged 65-79 years 7. Adolescent 13-18 years 8. Adult 19-44 years 9. Middle Aged 45-64 years 10. Type 2 Diabetes Mellitus 11. Young Adult 19-24 years 12. Birth to 1 mo 13. Type 1 Diabetes Mellitus
Provide patient population that should be included in the study
Ginkgo biloba for intermittent claudication
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Intermittent claudication 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Music interventions for preoperative anxiety
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Surgery 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease
1. Aged 80 and over 80+ years 2. Coronary artery restenosis 3. Adult 19-44 years 4. Middle Aged 45-64 years 5. Coronary Heart Disease 6. Young Adult 19-24 years 7. Aged 65-79 years
Provide patient population that should be included in the study
Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years 6. Threatened Premature Labour
Provide patient population that should be included in the study
Repetitive transcranial magnetic stimulation for improving function after stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Acupuncture for treating fibromyalgia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Fibromyalgia 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. HIV infection 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Antenatal perineal massage for reducing perineal trauma
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Normal Birth 4. Young Adult 19-24 years 5. Pregnancy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Garlic for peripheral arterial occlusive disease
1. Peripheral arterial occlusive disease
Provide patient population that should be included in the study
Oral evening primrose oil and borage oil for eczema
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Eczema 9. Birth to 1 mo 10. Dermatitis 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Chinese medicinal herbs for influenza
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Influenza 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Topical treatments for chronic plaque psoriasis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Plaque Psoriasis 6. Middle Aged 45-64 years 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Ginkgo biloba for tinnitus
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Tinnitus 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Nutritional interventions for reducing morbidity and mortality in people with HIV
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Acquired Immunodeficiency Syndrome 7. Young Adult 19-24 years 8. HIV infection 9. Aged 65-79 years 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Multinutrient fortification of human breast milk for preterm infants following hospital discharge
1. Birth to 1 mo 2. Low Birth Weight Infant 3. Preterm Infant
Provide patient population that should be included in the study
Reduced or modified dietary fat for preventing cardiovascular disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Chinese medicinal herbs for acute bronchitis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Acute Bronchitis 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Intermittent iron supplementation for improving nutrition and development in children under 12 years of age
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Birth to 1 mo
Provide patient population that should be included in the study
Omega‐3 fatty acids supplementation for autism spectrum disorders (ASD)
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Autism Spectrum Disorder 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Repetitive transcranial magnetic stimulation for tinnitus
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Tinnitus 6. Aged 65-79 years
Provide patient population that should be included in the study
Ginkgo biloba for cognitive impairment and dementia
1. Aged 80 and over 80+ years 2. Middle Aged 45-64 years 3. Mild Cognitive Impairment 4. Aged 65-79 years 5. Dementia
Provide patient population that should be included in the study
Massage and touch for dementia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Dementia
Provide patient population that should be included in the study
Interventions for improving health literacy in migrants
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years
Provide patient population that should be included in the study
Interventions for interpersonal communication about end of life care between health practitioners and affected people
1. Aged 80 and over 80+ years 2. Motor Neuron Disease 3. Caregiver 4. End stage pulmonary disease 5. Aged 65-79 years 6. Terminal Illness 7. End stage cardiac failure 8. Adult 19-44 years 9. End Stage Kidney Disease 10. Life-threatening Illness or event 11. Middle Aged 45-64 years 12. Young Adult 19-24 years 13. Chronic Disease
Provide patient population that should be included in the study
Interventions to enable communication for adult patients requiring an artificial airway with or without mechanical ventilator support
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Invasive Mechanical Ventilation 4. Middle Aged 45-64 years 5. Artificial Airway Management 6. Young Adult 19-24 years 7. Aged 65-79 years
Provide patient population that should be included in the study
Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD)
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Chronic Obstructive Pulmonary Disease 5. Aged 65-79 years
Provide patient population that should be included in the study
Adult patient access to electronic health records
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years
Provide patient population that should be included in the study
Interventions for improving medical students' interpersonal communication in medical consultations
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Student 6. Aged 65-79 years
Provide patient population that should be included in the study
Targeted client communication via mobile devices for improving sexual and reproductive health
1. Reproductive health 2. Child 6-12 years 3. Young Adult 19-24 years 4. Sexual health 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for improving medication‐taking ability and adherence in older adults prescribed multiple medications
1. Aged 80 and over 80+ years 2. Elderly 3. Aged 65-79 years
Provide patient population that should be included in the study
Telephone interventions, delivered by healthcare professionals, for providing education and psychosocial support for informal caregivers of adults with diagnosed illnesses
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Caregiver 6. Aged 65-79 years
Provide patient population that should be included in the study
Information or education interventions for adult intensive care unit (ICU) patients and their carers
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Critical Illness 6. Aged 65-79 years
Provide patient population that should be included in the study
E‐learning for health professionals
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Healthcare Professional 4. Young Adult 19-24 years 5. Aged 65-79 years
Provide patient population that should be included in the study
Different communication strategies for disclosing a diagnosis of schizophrenia and related disorders
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Schizophrenic Related Disorders 6. Schizophrenia 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Written information for patients (or parents of child patients) to reduce the use of antibiotics for acute upper respiratory tract infections in primary care
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Acute Upper Respiratory Infection 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Time‐limited home‐care reablement services for maintaining and improving the functional independence of older adults
1. Aged 80 and over 80+ years 2. Aged 65-79 years 3. Home Maintenance Assistance
Provide patient population that should be included in the study
Interventions to facilitate shared decision making to address antibiotic use for acute respiratory infections in primary care
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Acute Respiratory Tract Infection 7. Infant 1 to 23 mo 8. Healthcare Professional 9. Young Adult 19-24 years 10. Birth to 1 mo 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Training and supportive programs for palliative care volunteers in community settings
1. Voluntary Care
Provide patient population that should be included in the study
Virtual reality for treatment compliance for people with serious mental illness
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Severe mental disorder 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Schizophrenia 7. Aged 65-79 years
Provide patient population that should be included in the study
Culturally appropriate health education for people in ethnic minority groups with type 2 diabetes mellitus
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Ethnic Group 5. Type 2 Diabetes Mellitus 6. Young Adult 19-24 years 7. Aged 65-79 years
Provide patient population that should be included in the study
Information and communication technology based prompting for treatment compliance for people with serious mental illness
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Schizophrenic Related Disorders 6. Schizophrenia 7. Aged 65-79 years
Provide patient population that should be included in the study
Audio‐visual presentation of information for informed consent for participation in clinical trials
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Clinical trial participant
Provide patient population that should be included in the study
Mobile phone messaging reminders for attendance at healthcare appointments
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Face‐to‐face versus remote and web 2.0 interventions for promoting physical activity
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Face‐to‐face interventions for promoting physical activity
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Single versus multiple visits for endodontic treatment of permanent teeth
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Child 6-12 years 4. Middle Aged 45-64 years 5. Disorder Of Pulp Of Tooth 6. Young Adult 19-24 years 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Oral care measures for preventing nursing home‐acquired pneumonia
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Aged 65-79 years 10. Living In Residential Institution 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Periodontal therapy for primary or secondary prevention of cardiovascular disease in people with periodontitis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Periodontal Disease 10. Aged 65-79 years 11. Acute Disease Of Cardiovascular System 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Local interventions for the management of alveolar osteitis (dry socket)
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Tooth Extraction 6. Aged 65-79 years
Provide patient population that should be included in the study
Preprocedural mouth rinses for preventing transmission of infectious diseases through aerosols in dental healthcare providers
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Aerosol generating procedure 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Full‐mouth treatment modalities (within 24 hours) for periodontitis in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Periodontitis 5. Young Adult 19-24 years 6. Aged 65-79 years